These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

436 related items for PubMed ID: 1370410

  • 1. Differential responses to interleukin 2 define functionally distinct subsets of human natural killer cells.
    Baume DM, Robertson MJ, Levine H, Manley TJ, Schow PW, Ritz J.
    Eur J Immunol; 1992 Jan; 22(1):1-6. PubMed ID: 1370410
    [Abstract] [Full Text] [Related]

  • 2. CD56bright natural killer cell subsets: characterization of distinct functional responses to interleukin-2 and the c-kit ligand.
    Carson WE, Fehniger TA, Caligiuri MA.
    Eur J Immunol; 1997 Feb; 27(2):354-60. PubMed ID: 9045904
    [Abstract] [Full Text] [Related]

  • 3. Costimulatory signals are required for optimal proliferation of human natural killer cells.
    Robertson MJ, Manley TJ, Donahue C, Levine H, Ritz J.
    J Immunol; 1993 Mar 01; 150(5):1705-14. PubMed ID: 7679691
    [Abstract] [Full Text] [Related]

  • 4. Interleukin-7 selectively enhances natural kill cytotoxicity mediated by the CD56bright natural killer subpopulation.
    Dadmarz R, Bockstoce DC, Golub SH.
    Lymphokine Cytokine Res; 1994 Dec 01; 13(6):349-57. PubMed ID: 7535569
    [Abstract] [Full Text] [Related]

  • 5. Natural killer cells activated by interleukin 2 treatment in vivo respond to interleukin 2 primarily through the p75 receptor and maintain the p55 (TAC) negative phenotype.
    Weil-Hillman G, Voss SD, Fisch P, Schell K, Hank JA, Sosman JA, Sugamura K, Sondel PM.
    Cancer Res; 1990 May 01; 50(9):2683-91. PubMed ID: 1691679
    [Abstract] [Full Text] [Related]

  • 6. The effect of interleukin 2 and transforming growth factor-beta 2 (TGF-beta 2) on the proliferation and natural killer activity of decidual CD16- CD56bright natural killer cells.
    Saito S, Morii T, Enomoto M, Sakakura S, Nishikawa K, Narita N, Ichijo M.
    Cell Immunol; 1993 Dec 01; 152(2):605-13. PubMed ID: 7504983
    [Abstract] [Full Text] [Related]

  • 7. Differential expression and function of L-selectin on CD56bright and CD56dim natural killer cell subsets.
    Frey M, Packianathan NB, Fehniger TA, Ross ME, Wang WC, Stewart CC, Caligiuri MA, Evans SS.
    J Immunol; 1998 Jul 01; 161(1):400-8. PubMed ID: 9647249
    [Abstract] [Full Text] [Related]

  • 8. Induction of CD16+ CD56bright NK cells with antitumour cytotoxicity not only from CD16- CD56bright NK Cells but also from CD16- CD56dim NK cells.
    Takahashi E, Kuranaga N, Satoh K, Habu Y, Shinomiya N, Asano T, Seki S, Hayakawa M.
    Scand J Immunol; 2007 Feb 01; 65(2):126-38. PubMed ID: 17257217
    [Abstract] [Full Text] [Related]

  • 9. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor.
    Carson WE, Giri JG, Lindemann MJ, Linett ML, Ahdieh M, Paxton R, Anderson D, Eisenmann J, Grabstein K, Caligiuri MA.
    J Exp Med; 1994 Oct 01; 180(4):1395-403. PubMed ID: 7523571
    [Abstract] [Full Text] [Related]

  • 10. Costimulation of human natural killer cell proliferation: role of accessory cytokines and cell contact-dependent signals.
    Robertson MJ, Cameron C, Lazo S, Cochran KJ, Voss SD, Ritz J.
    Nat Immun; 1994 Oct 01; 15(5):213-26. PubMed ID: 9390270
    [Abstract] [Full Text] [Related]

  • 11. A comparative study of IL-12 (cytotoxic lymphocyte maturation factor)-, IL-2-, and IL-7-induced effects on immunomagnetically purified CD56+ NK cells.
    Naume B, Gately M, Espevik T.
    J Immunol; 1992 Apr 15; 148(8):2429-36. PubMed ID: 1373169
    [Abstract] [Full Text] [Related]

  • 12. Effects of transforming growth factor-beta on human lymphokine-activated killer cell precursors. Autocrine inhibition of cellular proliferation and differentiation to immune killer cells.
    Kasid A, Bell GI, Director EP.
    J Immunol; 1988 Jul 15; 141(2):690-8. PubMed ID: 3133414
    [Abstract] [Full Text] [Related]

  • 13. Human CD56bright and CD56dim natural killer cell subsets respond differentially to direct stimulation with Mycobacterium bovis bacillus Calmette-Guérin.
    Batoni G, Esin S, Favilli F, Pardini M, Bottai D, Maisetta G, Florio W, Campa M.
    Scand J Immunol; 2005 Dec 15; 62(6):498-506. PubMed ID: 16316416
    [Abstract] [Full Text] [Related]

  • 14. Gene expression and secretion of cytokines and cytokine receptors from highly purified CD56+ natural killer cells stimulated with interleukin-2, interleukin-7 and interleukin-12.
    Naume B, Johnsen AC, Espevik T, Sundan A.
    Eur J Immunol; 1993 Aug 15; 23(8):1831-8. PubMed ID: 7688307
    [Abstract] [Full Text] [Related]

  • 15. Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response.
    Fehniger TA, Shah MH, Turner MJ, VanDeusen JB, Whitman SP, Cooper MA, Suzuki K, Wechser M, Goodsaid F, Caligiuri MA.
    J Immunol; 1999 Apr 15; 162(8):4511-20. PubMed ID: 10201989
    [Abstract] [Full Text] [Related]

  • 16. A comparative study of immunomagnetic methods used for separation of human natural killer cells from peripheral blood.
    Øren A, Husebø C, Iversen AC, Austgulen R.
    J Immunol Methods; 2005 Aug 15; 303(1-2):1-10. PubMed ID: 16054641
    [Abstract] [Full Text] [Related]

  • 17. A novel functional cell surface dimer (Kp43) expressed by natural killer cells and T cell receptor-gamma/delta+ T lymphocytes. I. Inhibition of the IL-2-dependent proliferation by anti-Kp43 monoclonal antibody.
    Aramburu J, Balboa MA, Ramírez A, Silva A, Acevedo A, Sánchez-Madrid F, De Landázuri MO, López-Botet M.
    J Immunol; 1990 Apr 15; 144(8):3238-47. PubMed ID: 1691231
    [Abstract] [Full Text] [Related]

  • 18. G-CSF-mobilized CD34+ cells cultured in interleukin-2 and stem cell factor generate a phenotypically novel monocyte.
    Sconocchia G, Fujiwara H, Rezvani K, Keyvanfar K, El Ouriaghli F, Grube M, Melenhorst J, Hensel N, Barrett AJ.
    J Leukoc Biol; 2004 Dec 15; 76(6):1214-9. PubMed ID: 15345723
    [Abstract] [Full Text] [Related]

  • 19. Human natural killer cell adhesion molecules. Differential expression after activation and participation in cytolysis.
    Robertson MJ, Caligiuri MA, Manley TJ, Levine H, Ritz J.
    J Immunol; 1990 Nov 15; 145(10):3194-201. PubMed ID: 1700001
    [Abstract] [Full Text] [Related]

  • 20. Characterization of a cell line, NKL, derived from an aggressive human natural killer cell leukemia.
    Robertson MJ, Cochran KJ, Cameron C, Le JM, Tantravahi R, Ritz J.
    Exp Hematol; 1996 Feb 15; 24(3):406-15. PubMed ID: 8599969
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.